+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Alzheimer's Disease Clinical Trial Pipeline Highlights - 2019

  • ID: 4773881
  • Report
  • Region: Global
  • Fore Pharma
1 of 3

This report, Alzheimer's Disease Pipeline Highlights - 2019, provides most up-to-date information on key pipeline products in the global Alzheimer's Disease market. It covers emerging therapies for Alzheimer's Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives in tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Alzheimer's Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Alzheimer's Disease pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Alzheimer's Disease pipeline products by the company.

Short-term Launch Highlights:

Find out which Alzheimer's Disease pipeline products will be launched in the US and Ex-US to 2024.

Summary:

  • Alzheimer's Disease phase 3 clinical trial pipeline products
  • Alzheimer's Disease phase 2 clinical trial pipeline products
  • Alzheimer's Disease phase 1 clinical trial pipeline products
  • Alzheimer's Disease preclinical research pipeline products
  • Alzheimer's Disease discovery stage pipeline products
  • Alzheimer's Disease pipeline products short-term launch highlights

Note: Please allow up to 48 hours for delivery after order is placed.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Alzheimer's Disease Pipeline by Stages

2. Alzheimer's Disease Phase 3 Clinical Trial Insights

3. Alzheimer's Disease Phase 2 Clinical Trial Insights

4. Alzheimer's Disease Phase 1 Clinical Trial Insights

5. Alzheimer's Disease Preclinical Research Insights

6. Alzheimer's Disease Discovery Stage Insights

7. Appendix

8. Research Methodology

List of Tables:
Table 1: Alzheimer's Disease Phase 3 Clinical Trials, 2019
Table 2: Alzheimer's Disease Phase 2 Clinical Trials, 2019
Table 3: Alzheimer's Disease Phase 1 Clinical Trials, 2019
Table 4: Alzheimer's Disease Preclinical Research, 2019
Table 5: Alzheimer's Disease Discovery Stage, 2019

List of Figures:
Figure 1:: Alzheimer's Disease Pipeline Molecules by Clinical Trials Stage, 2019
Figure 2: Alzheimer's Disease Phase 3 Clinical Trial Highlights, 2019
Figure 3: Alzheimer's Disease Phase 2 Clinical Trial Highlights, 2019
Figure 4: Alzheimer's Disease Phase 1 Clinical Trial Highlights, 2019
Figure 5: Alzheimer's Disease Preclinical Research Highlights, 2019
Figure 6: Alzheimer's Disease Discovery Stage Highlights, 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4773881
Adroll
adroll